Viking Global Investors’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Buy |
11,681,333
+1,555,855
| +15% | +$26.1M | 0.57% | 57 |
|
|
2025
Q1 | $156M | Buy |
10,125,478
+3,621,993
| +56% | +$55.7M | 0.49% | 59 |
|
|
2024
Q4 | $143M | Sell |
6,503,485
-1,064,048
| -14% | -$23.5M | 0.46% | 54 |
|
|
2024
Q3 | $136M | Buy |
+7,567,533
| New | +$136M | 0.5% | 53 |
|
|
2016
Q4 | – | Sell |
-19,684,219
| Closed | -$906M | – | 77 |
|
|
2016
Q3 | $906M | Sell |
19,684,219
-8,052,436
| -29% | -$370M | 3.91% | 6 |
|
|
2016
Q2 | $1.39B | Sell |
27,736,655
-5,234,967
| -16% | -$263M | 5.92% | 4 |
|
|
2016
Q1 | $1.76B | Buy |
32,971,622
+7,927,847
| +32% | +$424M | 7.77% | 3 |
|
|
2015
Q4 | $1.64B | Buy |
25,043,775
+16,171,125
| +182% | +$1.06B | 6.2% | 4 |
|
|
2015
Q3 | $501M | Buy |
+8,872,650
| New | +$501M | 1.92% | 16 |
|
|
2015
Q2 | – | Sell |
-228,600
| Closed | -$14.2M | – | 68 |
|
|
2015
Q1 | $14.2M | Buy |
+228,600
| New | +$14.2M | 0.06% | 55 |
|